drugset / Trial / NCT02300038

Lidocaine and Neuroma Pain Related Modalities

NCT02300038 ↗

Completed 16 enrolled Uppsala University
RandomizedCrossoverDouble-blind

Summary

Background Subanesthetics concentrations of lidocaine are able to produce a differential block of the ectopic discharges, but not propagation of impulses, suppressing differentially the associated neuropathic pain symptoms. The aim of this study was to investigate the differences between the analgesic effects of lidocaine 0.5% and a control group of lidocaine 0.1% on several neuroma related pain modalities. Methods Sixteen patients with neuropathic pain due to painful neuromas caused by nerve injury participated in this randomized, double-blind experiment. The patterns of sensory changes were compared before and after injection of 1 ml lidocaine 0.5% and 0.1% close to the neuroma, the sessions being 1-2 weeks apart. Spontaneous and evoked pains were assessed using a visual analogue scale (VAS), quantitative and qualitative sensory testing.

Timeline

Start
2010-04
Primary completion
2013-08
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 0.1 % Other
Comparator Lidocaine Other / unclassified 0.5 % Other

Indications